SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001214659-16-010323
Filing Date
2016-03-15
Accepted
2016-03-15 16:24:00
Documents
5
Effectiveness Date
2016-03-15

Document Format Files

Seq Description Document Type Size
1 s315160defa14a.htm DEFA14A 43148
2 s315160defa14a1.jpg GRAPHIC 158470
3 s315160defa14a2.jpg GRAPHIC 268920
4 s315160defa14a3.jpg GRAPHIC 75964
5 s315160defa14a4.jpg GRAPHIC 23185
  Complete submission text file 0001214659-16-010323.txt   769650
Mailing Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 (510) 856-5600
Anthera Pharmaceuticals Inc (Filer) CIK: 0001316175 (see all company filings)

IRS No.: 201852016 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-34637 | Film No.: 161507202
SIC: 2834 Pharmaceutical Preparations